Transformable nanoparticles to bypass biological barriers in cancer treatment

Nanomedicine based drug delivery platforms provide an interesting avenue to explore for the future of cancer treatment. Here we discuss the barriers for drug delivery in cancer therapeutics and how nanomaterials have been designed to bypass these blockades through stimuli responsive transformation i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramachandran, Mythili, Ma, Zhao, Lin, Kai, De Souza, Cristabelle, Li, Yuanpei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595105/
https://www.ncbi.nlm.nih.gov/pubmed/36341301
http://dx.doi.org/10.1039/d2na00485b
_version_ 1784815571770015744
author Ramachandran, Mythili
Ma, Zhao
Lin, Kai
De Souza, Cristabelle
Li, Yuanpei
author_facet Ramachandran, Mythili
Ma, Zhao
Lin, Kai
De Souza, Cristabelle
Li, Yuanpei
author_sort Ramachandran, Mythili
collection PubMed
description Nanomedicine based drug delivery platforms provide an interesting avenue to explore for the future of cancer treatment. Here we discuss the barriers for drug delivery in cancer therapeutics and how nanomaterials have been designed to bypass these blockades through stimuli responsive transformation in the most recent update. Nanomaterials that address the challenges of each step provide a promising solution for new cancer therapeutics.
format Online
Article
Text
id pubmed-9595105
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher RSC
record_format MEDLINE/PubMed
spelling pubmed-95951052022-11-04 Transformable nanoparticles to bypass biological barriers in cancer treatment Ramachandran, Mythili Ma, Zhao Lin, Kai De Souza, Cristabelle Li, Yuanpei Nanoscale Adv Chemistry Nanomedicine based drug delivery platforms provide an interesting avenue to explore for the future of cancer treatment. Here we discuss the barriers for drug delivery in cancer therapeutics and how nanomaterials have been designed to bypass these blockades through stimuli responsive transformation in the most recent update. Nanomaterials that address the challenges of each step provide a promising solution for new cancer therapeutics. RSC 2022-09-14 /pmc/articles/PMC9595105/ /pubmed/36341301 http://dx.doi.org/10.1039/d2na00485b Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Ramachandran, Mythili
Ma, Zhao
Lin, Kai
De Souza, Cristabelle
Li, Yuanpei
Transformable nanoparticles to bypass biological barriers in cancer treatment
title Transformable nanoparticles to bypass biological barriers in cancer treatment
title_full Transformable nanoparticles to bypass biological barriers in cancer treatment
title_fullStr Transformable nanoparticles to bypass biological barriers in cancer treatment
title_full_unstemmed Transformable nanoparticles to bypass biological barriers in cancer treatment
title_short Transformable nanoparticles to bypass biological barriers in cancer treatment
title_sort transformable nanoparticles to bypass biological barriers in cancer treatment
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595105/
https://www.ncbi.nlm.nih.gov/pubmed/36341301
http://dx.doi.org/10.1039/d2na00485b
work_keys_str_mv AT ramachandranmythili transformablenanoparticlestobypassbiologicalbarriersincancertreatment
AT mazhao transformablenanoparticlestobypassbiologicalbarriersincancertreatment
AT linkai transformablenanoparticlestobypassbiologicalbarriersincancertreatment
AT desouzacristabelle transformablenanoparticlestobypassbiologicalbarriersincancertreatment
AT liyuanpei transformablenanoparticlestobypassbiologicalbarriersincancertreatment

Ejemplares similares